Objective:To study the effect of Xiao Chaihu Tang combined with intravenous chemotherapy on tumor markers and immune function in patients with advanced breast cancer.Methods: 76 patients with advanced breast cancer tr...Objective:To study the effect of Xiao Chaihu Tang combined with intravenous chemotherapy on tumor markers and immune function in patients with advanced breast cancer.Methods: 76 patients with advanced breast cancer treated in our hospital between May 2012 and November 2015 were collected and divided into the combined treatment group (n=34) who accepted Xiao Chaihu Tang combined with intravenous chemotherapy and the control group (n=42) who accepted intravenous chemotherapy alone according to different treatment, and the treatment cycle was 3 months for both groups. Before treatment and 3 months after treatment, ELISA method was used to detect serum levels of broad-spectrum tumor markers and breast cancer-specific tumor markers;flow cytometer was used to detect cellular immune function index levels, and turbidimetric immunoassay was used to detect humoral immune function index levels in peripheral blood.Results: Before treatment, differences in serum tumor marker levels as well as cellular immunity and humoral immunity index levels in peripheral blood were not statistically significant between two groups of patients (P>0.05);after 3 months of treatment, broad-spectrum tumor markers carcinoembryonic antigen (CEA), carbohydrate antigen 153 (CA153) and carbohydrate antigen 125 (CA125) levels in serum of combined treatment group were lower than those of control group, and breast cancer-specific tumor markers insulin-like growth factor-1 (IGF-1), midkine (MK), soluble E-cadherin (sEC) and thymidine kinase 1 (TK1) levels were lower than those of control group (P<0.05);CD3+ and CD4+ T lymphocyte levels as well as CD4+/CD8+ ratio in peripheral blood of combined treatment group were higher than those of control group while CD8+ T lymphocyte level was lower than that of control group, and immunoglobulin G (IgG), immunoglobulin A (IgA) and immunoglobulin M (IgM) levels in peripheral blood were higher than those of control group (P<0.05).Conclusions:Xiao Chaihu Tang combined with intravenous chemotherapy can decrease the severity of advanced breast cancer and optimize the body's immune function.展开更多
目的:基于网络药理学探讨柴胡桂枝干姜汤治疗腺样体肥大的作用机制。方法:通过中药系统药理学数据库与分析平台(traditional Chinese medicine systems pharmacology database and analysis platform,TCMSP),BATMAN-TCM数据库结合口服...目的:基于网络药理学探讨柴胡桂枝干姜汤治疗腺样体肥大的作用机制。方法:通过中药系统药理学数据库与分析平台(traditional Chinese medicine systems pharmacology database and analysis platform,TCMSP),BATMAN-TCM数据库结合口服利用度(oral bioavailability,OB)、类药性(drug-likeness,DL),药物半衰期(drug half-life,HL)检索柴胡桂枝干姜汤中柴胡、桂枝、干姜、黄芩、瓜蒌根、牡蛎、炙甘草的候选化合物及作用靶点信息,并通过Uniprot数据库将靶点校正为基因名;运用Genecards数据库获取腺样体肥大的相关靶点与基因,利用VENNY图获得柴胡桂枝干姜汤与腺样体肥大的交集靶点;STRING数据库来构建蛋白质相互作用PPI网络图;David数据库对交集靶点进行基因本体(gene ontology,GO)功能富集分析和KEGG通路富集分析;Cytoscape软件进行网络靶点特性分析。结果:筛选出柴胡桂枝干姜汤候选化合物65个,转化为有效靶点288个,得到腺样体肥大相关靶点781个,匹配得到共有靶点118个。GO富集主要涉及597个生物学过程、60个细胞组成和106个分子功能,KEGG通路分析主要涉及112条通路。结论:柴胡桂枝干姜汤治疗腺样体肥大是通过多靶点多通路发挥作用的。展开更多
目的以网络药理学研究结果为基础,对小建中汤中桂枝、甘草、生姜、大枣、白芍、饴糖6种中药开展深入研究,以期为小建中汤治疗脾胃虚寒类消化性溃疡作用机制研究提供新的依据及方向。方法基于中药系统药理学数据库与分析平台(TCMSP)、中...目的以网络药理学研究结果为基础,对小建中汤中桂枝、甘草、生姜、大枣、白芍、饴糖6种中药开展深入研究,以期为小建中汤治疗脾胃虚寒类消化性溃疡作用机制研究提供新的依据及方向。方法基于中药系统药理学数据库与分析平台(TCMSP)、中医药综合数据库(TCMID)获取小建中汤6种中草药的相关化学成分,并在Swiss Target Prediction中搜索活性化学成分潜在靶点;通过GeneCards数据库检索消化性溃疡、十二指肠溃疡、胃溃疡靶点和脾胃虚寒型消化性溃疡主要症状靶点;筛选出疾病主要症状、疾病和药物的共同靶点;运用Cytoscape Version 3.7.2软件绘制药物-化合物-靶点网络;利用STRING数据库绘制构建蛋白质相互作用(PPI)网络分析共同靶点之间的相互作用,找出可能的关键基因;利用R软件进行基因本体论(GO)和京都基因与基因组百科全书(KEGG)富集分析,分析治疗的作用机制;运用AutoDock及Pymol对关键靶点与相应活性成分进行分子对接验证,实验验证小建中汤对靶点蛋白、白细胞介素(IL)-6表达的影响。结果分析得到小建中汤具有128个活性化学成分作用于75个脾胃虚寒型消化性溃疡靶点,其中TP53、血管内皮生长因子(VEGF)、IL-6、胱天蛋白酶3(CASP3)、丝氨酸/苏氨酸蛋白激酶1(AKT1)、信号转导因子和转录激活因子3(STAT3)、丝裂原活化蛋白激酶3(MAPK3)、白蛋白(ALB)、表皮生长因子受体(EGFR)与非受体酪氨酸激酶(SRC)为核心靶点;而小建中汤治疗脾胃虚寒型消化性溃疡的核心活性成分是儿茶素、羟黄酮、芍药内苷C、拟雌内酯、草果甲素等;靶点基因主要富集于脂筏、膜微结构域、膜区、细胞小凹等细胞区域,作用于跨膜受体蛋白酪氨酸激酶活性、蛋白酪氨酸激酶活性、跨膜受体蛋白激酶活性、磷酸酶结合等分子功能,重要的是具有调节平滑肌细胞增殖和氧化应激反应。生物学通路则主要集中于磷脂酰肌醇3-激酶(PI3K)-Akt信号通路、缺氧诱导因子(HIF)-1信号通路、C型凝集素受体信号通路、胃癌等通路。分子对接结果显示,筛选的主要核心成分与其对应靶蛋白具有较好的结合活性。结论小建中汤通过网络药理学预测的作用机制多成分、多靶点、多通路治疗脾胃虚寒型消化性溃疡;实验验证小建中汤可下调靶点蛋白IL-6的表达,抑制肠上皮损伤。展开更多
文摘Objective:To study the effect of Xiao Chaihu Tang combined with intravenous chemotherapy on tumor markers and immune function in patients with advanced breast cancer.Methods: 76 patients with advanced breast cancer treated in our hospital between May 2012 and November 2015 were collected and divided into the combined treatment group (n=34) who accepted Xiao Chaihu Tang combined with intravenous chemotherapy and the control group (n=42) who accepted intravenous chemotherapy alone according to different treatment, and the treatment cycle was 3 months for both groups. Before treatment and 3 months after treatment, ELISA method was used to detect serum levels of broad-spectrum tumor markers and breast cancer-specific tumor markers;flow cytometer was used to detect cellular immune function index levels, and turbidimetric immunoassay was used to detect humoral immune function index levels in peripheral blood.Results: Before treatment, differences in serum tumor marker levels as well as cellular immunity and humoral immunity index levels in peripheral blood were not statistically significant between two groups of patients (P>0.05);after 3 months of treatment, broad-spectrum tumor markers carcinoembryonic antigen (CEA), carbohydrate antigen 153 (CA153) and carbohydrate antigen 125 (CA125) levels in serum of combined treatment group were lower than those of control group, and breast cancer-specific tumor markers insulin-like growth factor-1 (IGF-1), midkine (MK), soluble E-cadherin (sEC) and thymidine kinase 1 (TK1) levels were lower than those of control group (P<0.05);CD3+ and CD4+ T lymphocyte levels as well as CD4+/CD8+ ratio in peripheral blood of combined treatment group were higher than those of control group while CD8+ T lymphocyte level was lower than that of control group, and immunoglobulin G (IgG), immunoglobulin A (IgA) and immunoglobulin M (IgM) levels in peripheral blood were higher than those of control group (P<0.05).Conclusions:Xiao Chaihu Tang combined with intravenous chemotherapy can decrease the severity of advanced breast cancer and optimize the body's immune function.
文摘目的:基于网络药理学探讨柴胡桂枝干姜汤治疗腺样体肥大的作用机制。方法:通过中药系统药理学数据库与分析平台(traditional Chinese medicine systems pharmacology database and analysis platform,TCMSP),BATMAN-TCM数据库结合口服利用度(oral bioavailability,OB)、类药性(drug-likeness,DL),药物半衰期(drug half-life,HL)检索柴胡桂枝干姜汤中柴胡、桂枝、干姜、黄芩、瓜蒌根、牡蛎、炙甘草的候选化合物及作用靶点信息,并通过Uniprot数据库将靶点校正为基因名;运用Genecards数据库获取腺样体肥大的相关靶点与基因,利用VENNY图获得柴胡桂枝干姜汤与腺样体肥大的交集靶点;STRING数据库来构建蛋白质相互作用PPI网络图;David数据库对交集靶点进行基因本体(gene ontology,GO)功能富集分析和KEGG通路富集分析;Cytoscape软件进行网络靶点特性分析。结果:筛选出柴胡桂枝干姜汤候选化合物65个,转化为有效靶点288个,得到腺样体肥大相关靶点781个,匹配得到共有靶点118个。GO富集主要涉及597个生物学过程、60个细胞组成和106个分子功能,KEGG通路分析主要涉及112条通路。结论:柴胡桂枝干姜汤治疗腺样体肥大是通过多靶点多通路发挥作用的。
文摘目的以网络药理学研究结果为基础,对小建中汤中桂枝、甘草、生姜、大枣、白芍、饴糖6种中药开展深入研究,以期为小建中汤治疗脾胃虚寒类消化性溃疡作用机制研究提供新的依据及方向。方法基于中药系统药理学数据库与分析平台(TCMSP)、中医药综合数据库(TCMID)获取小建中汤6种中草药的相关化学成分,并在Swiss Target Prediction中搜索活性化学成分潜在靶点;通过GeneCards数据库检索消化性溃疡、十二指肠溃疡、胃溃疡靶点和脾胃虚寒型消化性溃疡主要症状靶点;筛选出疾病主要症状、疾病和药物的共同靶点;运用Cytoscape Version 3.7.2软件绘制药物-化合物-靶点网络;利用STRING数据库绘制构建蛋白质相互作用(PPI)网络分析共同靶点之间的相互作用,找出可能的关键基因;利用R软件进行基因本体论(GO)和京都基因与基因组百科全书(KEGG)富集分析,分析治疗的作用机制;运用AutoDock及Pymol对关键靶点与相应活性成分进行分子对接验证,实验验证小建中汤对靶点蛋白、白细胞介素(IL)-6表达的影响。结果分析得到小建中汤具有128个活性化学成分作用于75个脾胃虚寒型消化性溃疡靶点,其中TP53、血管内皮生长因子(VEGF)、IL-6、胱天蛋白酶3(CASP3)、丝氨酸/苏氨酸蛋白激酶1(AKT1)、信号转导因子和转录激活因子3(STAT3)、丝裂原活化蛋白激酶3(MAPK3)、白蛋白(ALB)、表皮生长因子受体(EGFR)与非受体酪氨酸激酶(SRC)为核心靶点;而小建中汤治疗脾胃虚寒型消化性溃疡的核心活性成分是儿茶素、羟黄酮、芍药内苷C、拟雌内酯、草果甲素等;靶点基因主要富集于脂筏、膜微结构域、膜区、细胞小凹等细胞区域,作用于跨膜受体蛋白酪氨酸激酶活性、蛋白酪氨酸激酶活性、跨膜受体蛋白激酶活性、磷酸酶结合等分子功能,重要的是具有调节平滑肌细胞增殖和氧化应激反应。生物学通路则主要集中于磷脂酰肌醇3-激酶(PI3K)-Akt信号通路、缺氧诱导因子(HIF)-1信号通路、C型凝集素受体信号通路、胃癌等通路。分子对接结果显示,筛选的主要核心成分与其对应靶蛋白具有较好的结合活性。结论小建中汤通过网络药理学预测的作用机制多成分、多靶点、多通路治疗脾胃虚寒型消化性溃疡;实验验证小建中汤可下调靶点蛋白IL-6的表达,抑制肠上皮损伤。
